Device_News
25 January 2018

New test developed for virulent STI

Partnerships, Products

You may have never heard of it, but Mycoplasma genitalium – MG for short – is one of the most common sexually transmitted infections in Australia. Like chlamydia, MG can appear symptomless but, left untreated, can cause infertility, miscarriage and premature birth for pregnant women. The bacterium is stubbornly resistant to treatment with antibiotics. SpeeDx has developed a simple test that could dramatically change treatment options.

Listen to Dr. Catriona Bradshaw speak on ABC Radio about her experience using the SpeeDx ResistancePlus® MG test to manage MG infections in her clinic.

Click here to access the interview

Print page